Instituto de Salud Carlos III (ISCIII) | SPAIN | Coordinator
ISCIII is the leading Public Research Institution which funds, administers, and performs biomedical research in Spain. It is administratively dependent from the Spanish Ministry of Economy, Industry and Competitiveness and functionally dually dependent from the latest and the Spanish Ministry of Health, Social Services and Equality. In addition to its research activities, ISCIII is a national reference centre for specialized techniques servicing the Spanish National Health System, carries out teaching and training activities, funds research projects and human resources for health sciences through the Strategic Action for Health (AES in Spanish), and houses the National Library of Health Sciences. ISCIII is involved in basic and advanced training of health professionals. ISCIII funds Spanish health research networks, supports associated research institutes, consortia and platforms. ISCIII actively participates in research projects funded by the EU Framework programmes and CHAFEA. Only in FP7, this institution participated in 46 projects, (8 as coordinator). So far in H2020, ISCIII participates in 27 projects (3 as coordinator). ISCIII has been awarded the Logo “Human Resources Excellence in Research”. As a health research funding agency, ISCIII participates in different transnational programmes related to health, such as ERA-nets, EDCTP, AAL, Joint Programming Initiatives (Neurodegenerative Diseases -JPND-, Healthy Diet for a Healthy Life -JPI HDHL-, More Years Better Lives -JPI MYBL-, and Antimicrobial Resistance -JPI AMR), and in four European infrastructures (ESFRI landmarks EATRIS, ECRIN, EU-Openscreen and ELIXIR). ISCIII represents Spain in RIMAIS (Ibero-American Ministerial Network of Learning and Health Research).
German Center for Aerospace Research, Project Management Agency (DLR) | GERMANY | Participant
DLR is a non-governmental, non-profit German research organisation. Its Project Management Agency DLR-PT is mandated by the Federal Ministry of Education and Research (BMBF) and other ministries with regard to implementation and management of governmental programmes for research funding. Being a trustee for the funding budget, DLR-PT administrates, with a staff of over 850, approximately 1.1 billion € p.a. Fields covered – amongst others – are information technology, education, environment, life sciences and international cooperation. Within the life sciences, the “health research” department of PT-DLR manages the areas of clinical research and biomedical research for BMBF, administrating a total of about 220 Mio. €. The department “European and International Cooperation” has a strong background in R&D strategy and policy implementation with particular emphasis on international relations and cooperation activities. It also coordinates the German Network of National Contact Points (NCPs) and hosts NCPs for Research Infrastructures, ERC, INCO, Legal & Financial Issues etc. DLR has participated / is participating in ERA-NETs under the FP7 and H2020 programmes such as: E-RARE-2, NEURON II, as well as ERA-NETs Cofund under the H2020 program, such as JPco-fuND, NEURON Cofund, E-RARE-3 and, ERA-HDHL, ERACVD. DLR has been / is involved in various INCO-projects and CSA targeting Latin America and the Caribbean and has coordinated the ERANet-LAC project. Currently, DLR coordinates the EU-LAC Interest Group which plans and implements joint funding actions, involving more than 30 funding agencies from EU and LAC. In the context of personalised medicine, DLR has coordinated the CSA PerMed resulting in the publication of a strategic research and innovation agenda (SRIA) for Personalised Medicine. This SRIA paved the ground for ICPerMed. Currently DLR is coordinating the CSA “ICPerMed Secretariat” in support of ICPerMed. DLR is also partner of the recently established ERANET-Cofund ERAPerMed. DLR is implementing the German national action plan “Individualized Medicine” for the BMBF with a budget over 360 Mio €.
The Oswaldo Cruz Foundation (Fiocruz) | BRAZIL | Participant
The Oswaldo Cruz Foundation (Fiocruz) is recognized both locally and internationally – received several prizes including the Order of Scientific Merit, granted by the Brazilian government, and an award granted by the World Federation of Public Health Associations. Its activities include teaching, research and production, focusing on technological development and innovations that meet the core needs of the population in the health area. Fiocruz is the science and technology agency of the Ministry of Health, and an important asset to the Unified Health System (SUS). Its activities are diverse and include clinical and epidemiological research, as well as studies on human, social and life sciences; scientific expeditions; training of human resources, from the technical to the doctorate level; providing hospital-based and ambulatory care services, as well as reference health surveillance; and manufacturing drugs, vaccines,and other strategic input, in addition to subsidizing public policies. It is this array of activities that grants the Foundation its importance not only at a local level, but also at an International level, as it participates in important international exchanges. Its mission is “produce, disseminate and share knowledge and technologies aimed at the strengthening and consolidation of the Unified Health System (SUS) and contribute to the promotion of health and quality of life of the population. Besides the reduction of social inequalities and the national dynamics of innovation, with the defense of the right to health and full citizenship as central values..
Sociedad para el Fomento de la Innovación Tecnológica (INNOVATEC) | SPAIN | Participant
Innovatec is an independent Spanish firm, offering knowledge and expertise to perform and coordinate Research, Development and innovation projects. It was established in 1999 as a Spin-off from the Technology Transfer Unit of the University of Alcalá (Madrid, Spain). The areas of expertise include evaluation of R&I projects (national, European and international), research and Innovation (R&I) management tools, coordination of R&I projects, development of technology transfer programmes, design of in-house plans and strategies for R&I promotion, planning, organization and the coordination of scientific events and design and implementation of knolwledge trasnfer and dissemination strategies. Innovatec work is based on wide R&D multidisciplinary expertise, desk research techniques, maximum use of available information technologies, and our flexibility to work on a variety of projects. Innovatec was the coordinator of the FP7 SICA project EVAL-HEALTH , with 9 participants both from Europe and abroad. Innovatec was also the coordinator of the H2020 project RegHealth-RI (and participant in the FP7 CSA project EU-LAC Health. Moreover Innovatec was partner in the H2020 project COLUMBUS and is now participant of the H2020 project HEIRRI and InRoad.
Italian Ministry of Health | ITALY | Participant
The Italian Ministry of Health (MoH-IT) represents the central level of the Italian National Health Service (IT-NHS) and is responsible for the overall planning and control and to establish the IT-NHS targets and most important measures to be implemented. The MoH-IT is the leading body of the national information system on health, which includes data on hospital admissions and health interventions. It is also responsible for the overall coordination of Prevention Programmes, in particular those oriented at the promotion of a correct life-style, surveillance of chronic diseases and related risk factors, promotion and surveillance of secondary prevention. It is entitled of the resource management and direct funding of operational health research, and it is the governing body for the legislation on medical devices and health professionals. The participating Directorate General for Research and Innovation in Healthcare has the mandate to coordinate the activities in health prevention, health research, international and EU relations and external communication activities. It also promotes actions and grants in several fields of public health in cooperation with other MoH-IT Directorates.
Comisión Nacional de Investigación Científica y Tecnológica | CHILE | Participant
CONICYT was created in 1967 as an advisory body to the Government in Science and Technology (S&T) matters. CONICYT acts as the coordinating entity that works jointly within the Chilean Science and Technology System, by promoting and strengthening scientific and technological research, the training of human resources, the development of new areas of knowledge and innovation. To this purpose, CONICYT implements public resources allocated to these matters. The International Cooperation Programme (PCI) at CONICYT carries out the international cooperation policy on science and technology of the Government of Chile. It actively enhances the international cooperation of the national research community. The Chile-European Union Liaison Office is part of PCI and implements the S&T Cooperation Agreement between Chile and the European Union, through policy dialogue and the promotion of the Chilean participation in the EU Framework Programmes. The Liaison Office has a strong and continuous partnership with its counterparts in Latin America and Europe, exchanging information and best practices on a regular basis. PCI has actively participated in twelve EU-funded projects, including two ERANETs.
European Clinical Research Infrastructure Network | FRANCE | Participant
The European Clinical Research Infrastructure Network (ECRIN), is a sustainable, not-for-profit, distributed infrastructure with the legal status of a European Research Infrastructure Consortium (ERIC). ECRIN provides support for the planning and implementation of multinational clinical research projects in Europe. ECRIN currently has eight Member Countries (France, Germany, Spain, Italy, Portugal, Hungary, Czech Republic and Norway) and one Observer Country (Switzerland). Additional countries are about to join. ECRIN services and tools. ECRIN provides services for the management of multinational -investigators initiated and SME sponsored- trials; central services and distributed services provided by the ECRIN partner in each country involved. As part of its trial support activities, ECRIN develops and maintains freely accessible tools such as databases on regulatory and ethical issues, outcome measures, and risk-based monitoring. ECRIN contributes to capacity building projects aiming to establish shared services in biomedical areas, and to foster international cooperation in non-commercial trials. ECRIN’s ‘distributed infrastructure’ includes a Core Team based in Paris, France (headquarters) and European Correspondents (EuCos) working in each Member and Observer Country and hosted by the national scientific partners. ECRIN has also partners in other countries in Europe and internationally with which it collaborates.
National Research and Innovation Agency | URUGUAY | Participant
The National Research and Innovation Agency (ANII) is a government agency that promotes and encourages research and implementation of new knowledge produced and social equality for the country. As main objectives include: design, organization and administration of Plans, Programs and Instruments oriented toward the scientific-technological development, as well as the reinforcement and deployment of innovation capabilities. To achieve Its goal, ANII works in four action fields: RESEARCH: With funds destined to scientific and technological research, and to applied research, ANII finances original projects in order to generate new knowledge. INNOVATION: By means of the design and management of funding instruments, ANII aims at sharing the risk of innovating with uruguayan companies, as well as promoting the innovation culture. ENTREPRENEURSHIP: fostering the entrepreneurial spirit, and at funding and working together with institutions that support entrepreneurs during the design, preparation and pre-incubation stages of their projects. EDUCATION: By means of the National Scholarships System, ANII encourages postgraduate studies by providing grants for Masters, PhDs, and Post-Docs, as well as mobility and training grants.
Instituto Conmemorativo Gorgas de Estudios de la Salud | PANAMA | Participant
The Gorgas Memorial Institute for Health Studies (GORGAS) was established as a biomedical research laboratory in Panama ninety years ago. Its expertise in studying and controlling infectious diseases goes back to 1928 when it became necessary to solve a public health problem of major importance, the eradication of urban yellow fever and the control of malaria in the cities of Panama and Colon. Since inception, GORGAS has been a focal point in Central America for infectious disease studies, a role it continues today through research programs in virology, bacteriology, immunology, vector-borne disease, zoonosis and parasitology. More recently, GORGAS´s diagnostic abilities became apparent in 2006 when this institute was able to correlate an unexpected number of people with acute renal failure, neurological disturbances and deaths to the contamination of cough syrup contaminated with diethyleneglycol.GORGAS serves as the National Reference Laboratory and the primary Research Center for Health Studies in Panama. Half of Institute funds comes from the Government and half from national and international research grants. It’s a non-profit organization which has a general director who is chosen by national contest every five years. The Gorgas Institute is involved in basic and clinical training of health professionals, residents, and interns to cope with the health care demands of our Health System. In addition, GORGAS has a long history of collaboration with the CDC, PAHO, John Hopkins University, Harvard University, Instituto Carlos III (Spain), other U.S. and Latin American Universities as well as with Ministries of Health from Central America and the Caribbean region.GORGAS, from Panama, and ISCIII, from Spain, share a constituency at the Joint Coordinating Board of the Tropical Diseases Research Program of World Health Organization.
Chief Scientist Office, Ministry of Health | ISRAEL | Participant
The Chief Scientist Office (CSO) of Israeli Ministry of Health (MOH) through its Medical Research Administration is a pivotal organization in Israel for managing and funding of bio-medical and medical research. Our strategic approach is to support investigator-initiated, health-related research projects performed in hospitals, universities and research institutes. Grant proposals received in response to public Calls for Applications issued by the Research Fund, are peer reviewed in various research-disciplines review committees (Study Sections. CSO-MOH is also mandated to regulate animal experimentation, genetic human experimentation and homeland security aspects of biomedical research in Israel.
Secretaría de Gobierno de Ciencia, Tecnología e Innovación Productiva (SGCTeIP) | ARGENTINA | Participant
The Secretariat of Government of Science, Technology and Productive Innovation (SGCTeIP) establishes policies and coordinates actions aimed to strengthen the country’s capacity to respond to priority sectoral and social problems in order to improve society’s quality of life. The main role of the National Directorate for Cooperation and Institutional Integration is to coordinate cooperation and institutional integration actions among the Secretariat and the agencies and authorities of the different State powers at the national, provincial, municipal level and at the level of the Autonomous City of Buenos Aires, regional authorities and intermediate institutions, as well as to design and implement public policies aimed at young players in the field of science, technology and productive innovation to promote their support. It also participates in international technical cooperation efforts related to science, technology and productive innovation. Under the EU- Argentina S&T Cooperation Agreement, the country participated in a number of technological cooperation initiatives, with one of the highest success rates for Third Countries participating in the H2020. The Secretariat of Government of Science, Technology and Productive Innovation has participated (as coordinator and partner) in the following more than twenty-five FP7 and H2020, such as: EULARINET (2008-2012); INCONTACT (2008-2013), PeopleNetwork+ (2011-2013), ALCUE NET (2012-2017), ERANet- LAC (2013-2017), EU LAC FOCUS (2016-2019), EXEDRA (2016-2019), etc.